Reported Earnings • Jul 18
Second quarter 2026 earnings released: EPS: CN¥0.031 (vs CN¥0.036 loss in 2Q 2025) Second quarter 2026 results: EPS: CN¥0.031 (up from CN¥0.036 loss in 2Q 2025). Revenue: CN¥251.9m (up 6.9% from 2Q 2025). Net income: CN¥31.7m (up CN¥67.9m from 2Q 2025). Profit margin: 13% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Ankündigung • Jun 30
Danhua Chemical Technology Co.,Ltd to Report First Half, 2026 Results on Aug 14, 2026 Danhua Chemical Technology Co.,Ltd announced that they will report first half, 2026 results on Aug 14, 2026 Ankündigung • Jun 02
Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 22, 2026 Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 22, 2026, at 14:00 China Standard Time. Location: 4F, No. 295, Zhaowuda Road, Saihan District, Hohhot, Inner Mongolia China New Risk • May 07
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -CN¥128m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 5.3% per year over the past 5 years. Minor Risk Less than 1 year of cash runway based on current free cash flow (-CN¥128m). Reported Earnings • Apr 30
Full year 2025 earnings released: CN¥0.17 loss per share (vs CN¥0.30 loss in FY 2024) Full year 2025 results: CN¥0.17 loss per share (improved from CN¥0.30 loss in FY 2024). Revenue: CN¥826.1m (up 7.3% from FY 2024). Net loss: CN¥169.4m (loss narrowed 45% from FY 2024). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. New Risk • Mar 31
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 4.8% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.4% average weekly change). Ankündigung • Mar 30
Danhua Chemical Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026 Danhua Chemical Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026 Ankündigung • Dec 26
Danhua Chemical Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 30, 2026 Danhua Chemical Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 30, 2026 Reported Earnings • Oct 31
Third quarter 2025 earnings released: CN¥0.016 loss per share (vs CN¥0.085 loss in 3Q 2024) Third quarter 2025 results: CN¥0.016 loss per share (improved from CN¥0.085 loss in 3Q 2024). Revenue: CN¥214.2m (up 14% from 3Q 2024). Net loss: CN¥16.0m (loss narrowed 82% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 1% per year. Ankündigung • Sep 30
Danhua Chemical Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025 Danhua Chemical Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025 Reported Earnings • Aug 17
Second quarter 2025 earnings released: CN¥0.036 loss per share (vs CN¥0.06 loss in 2Q 2024) Second quarter 2025 results: CN¥0.036 loss per share (improved from CN¥0.06 loss in 2Q 2024). Revenue: CN¥235.7m (up 19% from 2Q 2024). Net loss: CN¥36.2m (loss narrowed 41% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Ankündigung • Jun 30
Danhua Chemical Technology Co.,Ltd to Report First Half, 2025 Results on Aug 19, 2025 Danhua Chemical Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 19, 2025 Ankündigung • Jun 06
Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 27, 2025 Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 27, 2025, at 14:00 China Standard Time. Location: No. 52, Zhaowuda Road, Saihan District, Hohhot, Inner Mongolia China New Risk • May 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥18m free cash flow). Earnings have declined by 1.9% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change). Reported Earnings • Apr 11
Full year 2024 earnings released: CN¥0.30 loss per share (vs CN¥0.39 loss in FY 2023) Full year 2024 results: CN¥0.30 loss per share (improved from CN¥0.39 loss in FY 2023). Revenue: CN¥769.9m (down 11% from FY 2023). Net loss: CN¥307.5m (loss narrowed 22% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 28
Danhua Chemical Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025 Danhua Chemical Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025 New Risk • Feb 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥74m free cash flow). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.7% average weekly change). Ankündigung • Dec 27
Danhua Chemical Technology Co.,Ltd to Report Fiscal Year 2024 Results on Apr 11, 2025 Danhua Chemical Technology Co.,Ltd announced that they will report fiscal year 2024 results on Apr 11, 2025 New Risk • Oct 31
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥74m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥74m free cash flow). Earnings have declined by 1.7% per year over the past 5 years. Ankündigung • Sep 30
Danhua Chemical Technology Co.,Ltd to Report Q3, 2024 Results on Oct 31, 2024 Danhua Chemical Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Aug 30
Second quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.046 loss in 2Q 2023) Second quarter 2024 results: CN¥0.06 loss per share (further deteriorated from CN¥0.046 loss in 2Q 2023). Revenue: CN¥197.9m (down 25% from 2Q 2023). Net loss: CN¥61.6m (loss widened 33% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Ankündigung • Jun 28
Danhua Chemical Technology Co.,Ltd to Report First Half, 2024 Results on Aug 30, 2024 Danhua Chemical Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 30, 2024 Ankündigung • Jun 06
Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 25, 2024 Danhua Chemical Technology Co.,Ltd, Annual General Meeting, Jun 25, 2024, at 14:00 China Standard Time. Location: No. 333, Lanling Road, Danyang, Jiangsu China Reported Earnings • Apr 30
Full year 2023 earnings released: CN¥0.39 loss per share (vs CN¥0.29 loss in FY 2022) Full year 2023 results: CN¥0.39 loss per share (further deteriorated from CN¥0.29 loss in FY 2022). Revenue: CN¥861.1m (down 7.8% from FY 2022). Net loss: CN¥393.0m (loss widened 34% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 12% per year. Ankündigung • Mar 29
Danhua Chemical Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024 Danhua Chemical Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024 Ankündigung • Dec 30
Danhua Chemical Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 19, 2024 Danhua Chemical Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 19, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: CN¥0.087 loss per share (vs CN¥0.038 loss in 3Q 2022) Third quarter 2023 results: CN¥0.087 loss per share (further deteriorated from CN¥0.038 loss in 3Q 2022). Revenue: CN¥150.7m (down 35% from 3Q 2022). Net loss: CN¥88.8m (loss widened 132% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 3% per year. Reported Earnings • Apr 22
Full year 2022 earnings released: CN¥0.29 loss per share (vs CN¥0.10 loss in FY 2021) Full year 2022 results: CN¥0.29 loss per share (further deteriorated from CN¥0.10 loss in FY 2021). Revenue: CN¥933.8m (down 14% from FY 2021). Net loss: CN¥293.0m (loss widened 182% from FY 2021). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: CN¥0.038 loss per share (vs CN¥0.027 loss in 3Q 2021) Third quarter 2022 results: CN¥0.038 loss per share (further deteriorated from CN¥0.027 loss in 3Q 2021). Revenue: CN¥230.7m (up 2.1% from 3Q 2021). Net loss: CN¥38.2m (loss widened 41% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 29
Second quarter 2022 earnings released: CN¥0.004 loss per share (vs CN¥0.001 loss in 2Q 2021) Second quarter 2022 results: CN¥0.004 loss per share (down from CN¥0.001 loss in 2Q 2021). Revenue: CN¥266.5m (up 1.4% from 2Q 2021). Net loss: CN¥4.14m (loss widened CN¥3.62m from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 29
First quarter 2022 earnings released: CN¥0.002 loss per share (vs CN¥0.023 loss in 1Q 2021) First quarter 2022 results: CN¥0.002 loss per share (up from CN¥0.023 loss in 1Q 2021). Revenue: CN¥262.2m (down 2.0% from 1Q 2021). Net loss: CN¥1.77m (loss narrowed 92% from 1Q 2021). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 21
Full year 2021 earnings released: CN¥0.10 loss per share (vs CN¥0.36 loss in FY 2020) Full year 2021 results: CN¥0.10 loss per share (up from CN¥0.36 loss in FY 2020). Revenue: CN¥1.09b (up 1.1% from FY 2020). Net loss: CN¥104.1m (loss narrowed 72% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Board Change • Dec 22
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 10 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Ankündigung • Sep 24
Shanghai North Bund (Group) Co., Ltd. cancelled the acquisition of the Framework Agreement for the Transfer of Shares to acquire 15% stake in Danhua Chemical Technology Co.,Ltd (SHSE:600844) from Jiangsu Danhua Group Co.,Ltd. Shanghai North Bund (Group) Co., Ltd. signed the Framework Agreement for the Transfer of Shares to acquire 15% stake in Danhua Chemical Technology Co.,Ltd (SHSE:600844) from Jiangsu Danhua Group Co.,Ltd. on January 21, 2021. The North Bund Group pays cash to Danhua Group at the price agreed in this agreement as the consideration for the target shares. Under the terms of transaction, Shanghai North Bund (Group) Co., Ltd. will acquire 152.5 million shares. Upon completion, the company’s controlling shareholder will be changed to the North Bund Group, and the actual controller will be changed to the State-owned Assets Supervision of Shanghai Hongkou District Management committee.
Shanghai North Bund (Group) Co., Ltd. cancelled the acquisition of the Framework Agreement for the Transfer of Shares to acquire 15% stake in Danhua Chemical Technology Co.,Ltd (SHSE:600844) from Jiangsu Danhua Group Co.,Ltd. on September 22, 2021. both parties believed that the timing and conditions of the transfer were not yet ripe and decided to terminate the transfer of shares. Reported Earnings • Aug 31
Second quarter 2021 earnings released: CN¥0.001 loss per share (vs CN¥0.077 loss in 2Q 2020) The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2021 results: Revenue: CN¥262.9m (down 1.4% from 2Q 2020). Net loss: CN¥518.3k (loss narrowed 99% from 2Q 2020). Reported Earnings • May 04
First quarter 2021 earnings released: CN¥0.023 loss per share (vs CN¥0.058 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: CN¥267.6m (up 23% from 1Q 2020). Net loss: CN¥23.4m (loss narrowed 60% from 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 16
Full year 2020 earnings released: CN¥0.36 loss per share (vs CN¥0.27 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: CN¥1.08b (down 13% from FY 2019). Net loss: CN¥367.2m (loss widened 36% from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Mar 11
New 90-day high: CN¥5.89 The company is up 64% from its price of CN¥3.60 on 11 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Jan 19
New 90-day high: CN¥5.04 The company is up 73% from its price of CN¥2.91 on 21 October 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Ankündigung • Oct 30
Danhua Chemical Technology Co.,Ltd to Report Q3, 2020 Results on Oct 31, 2020 Danhua Chemical Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 31, 2020 Ankündigung • Jul 17
Danhua Chemical Technology Co.,Ltd to Report First Half, 2020 Results on Aug 29, 2020 Danhua Chemical Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 29, 2020 
